Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: Diagnostic and possible therapeutic implications

Modern Pathology

Volumn 19, Issue 6, 2006, Pages 797-803

  Orlandi, Augusto ^a   Ferlosio, Amedeo ^a   Ciucci, Alessandro ^a   Francesconi, Arianna ^a   Lifschitz Mercer, Beatriz ^b   Gabbiani, Giulio ^c   Spagnoli, Luigi G ^a   Czernobilsky, Bernard ^d  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF GENEVA   (Switzerland)

^d Patho Lab Laboratories   (Israel)

Author keywords

Cell differentiation; CRBP 1; Endometrial cancer; Endometrial hyperplasia; Retinoid receptor

Indexed keywords

ANTIBODY; CELLULAR RETINOL BINDING PROTEIN 1; ESTROGEN RECEPTOR; PARAFFIN; PROGESTERONE RECEPTOR; RETINOL;

ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODETECTION; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL; TISSUE SECTION;

ADENOCARCINOMA; AGED; CARCINOMA, ENDOMETRIOID; CYTOPLASM; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETINOL-BINDING PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 33646895421     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800586     Document Type: Article

References (43)

1. Blomhoff R. Transport and metabolism of vitamin A. Nutr Rev 1994;52:S13-S23.
2. Underwood BA. Vitamin A and cancer prevention conference-an introduction. J Natl Cancer Inst 1984;73:1371-1372.
3. Boettger-Tong HL, Stancel GM. Retinoic acid inhibits oestrogen-induced uterine stromal and myometrial cell proliferation. Endocrinology 1995;136:2975-2983.
4. Wolbach SB, Howe PR. Nutrition classics. J Exp Med 1925;42:753-777.
5. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. Nutr Rev 1978;36:16-19.
6. Ong DE. Cellular transport and metabolism of vitamin A: role of the cellular retinoid-binding proteins. Nutr Rev 1994;52:24-31.
7. Napoli Jl, Posh KP, Fiorella PD, et al. Physiological occurrence, biosynthesis and metabolism of retinoic acid: evidence for roles of cellular retinol-binding protein (CRBP) and cellular retinoic acid-binding protein (CRABP) in the pathway of retinoic acid homeostasis. Biomed Pharmacother 1991;45:131-143.
8. Vogel S, Mendelsohn CL, Mertz JR, et al. Characterization of a new member of the fatty acid-binding protein family that binds all-trans-retinol. J Biol Chem 2001;276:1353-1360.
9. Napoli JL. Biosynthesis and metabolism of retinoic acid: roles of CRBP and CRABP in retinoic acid: roles of CRBP and CRABP in retinoic acid homeostasis. J Nutr 1993;123:362-366.
10. Napoli JL. A gene knockout corroborates the integral function of cellular retinol-binding protein in retinoid metabolism. Nutr Rev 2000;58:230-241.
11. Farias EF, Ong DE, Ghyselinck NB, et al. Retinol-binding protein I, a regulator of breast epithelial retinoic acid receptor activity, cell differentiation, and tumorigenicity. J Natl Cancer Inst 2005;97:21-29.
12. Cvetkoviæ D, Williams SJ, Hamilton TC. Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. Clin Cancer Res 2003;9:1013-1020.
13. Lotan R. A crucial role for cellular retinol-binding protein I in retinoid signaling. J Natl Cancer Inst 2005;97:3-4.
14. Siddiqui NA, Loughney A, Thomas EJ, et al. Cellular retinoid binding proteins and nuclear retinoic acid receptors in endometrial epithelial cells. Hum Reprod 1994;8:1410-1416.
15. Dallenbach-Hellweg G. Histopathology of the Endometrium. Springer-Verlag and Heidelberg: Berlin-New York, 1981, pp 159-216.
16. Neuville P, Geinoz A, Benzonana G, et al. Cellular retinol-binding protein-1 is expressed by distinct subsets of rat arterial smooth muscle cells in vitro and in vivo. Am J Pathol 1997;150:509-521.
17. Orlandi A, Ferlosio A, Ciucci A, et al. Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications. Histopathology 2004;45:511-517.
18. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
19. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet 2005;366:491-505.
20. Silverberg SG, Kurman RJ. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. In Atlas of Tumor Pathology. AFIP: Washington, DC, 1991, pp 47-89.
21. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002;9:145-184.
22. Ellenson LH, Wu TC. Focus on endometrial and cervical cancer. Cancer Cell 2004;5:533-538.
23. Mutter GL, Lin MC, Fitzgerald JT, et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000;92:924-930.
24. Orlandi A, Ferlosio A, Ciucci A, et al. Cellular retinol-binding protein-1 expression in endometrial stromal cells: physiopathological and diagnostic implications. Histopathology 2004;45:511-517.
25. Kanaya T, Kyo S, Maida Y, et al. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers. Oncogene 2003;22:2352-2360.
26. Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol 2004;35:649-662.
27. DiSaia PJ, Creasman WT, Boronow RC, et al. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009-1015.
28. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
29. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17.
30. Kurman RJ (ed). Blaustein's Pathology of the Female Genital Tract, 5th edn. Springer-Verlag: New York, 2002, pp 467-503.
31. Wilson TO, Podratz KC, Gaffey TA, et al. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol 1990;162:418-423; discussion 423-426.
32. Matias-Guiu X, Catasus L, Bussaglia E, et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol 2001;32:569-577.
33. Tashiro H, Isacson C, Levine R, et al. p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis. Am J Pathol 1997;150:177-185.
34. Bergeron C, Nogales FF, Masseroli M. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-1108.
35. Shutter J, Wright Jr TC. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia. Int J Gynecol Pathol 2005;24:313-318.
36. Liu RZ, Denovan-Wright EM, Degrave A, et al. Spatio-temporal distribution of cellular retinol-binding protein gene transcripts (CRBPI and CRBPII) in the developing and adult zebrafish (Danio rerio). Eur J Biochem 2004;271:339-348.
37. Tannous-Khuri L, Hillemanns P, Rajan N, et al. Expression of cellular retinol- and cellular retinoic acid-binding proteins in the rat cervical epithelium is regulated by endocrine stimuli during normal squamous metaplasia. Am J Pathol 1994;144:148-159.
38. Hillemanns P, Tannous-Khuri L, Koulos JP, et al. Localization of cellular retinoid-binding proteins in human cervical intraepithelial neoplasia and invasive carcinoma. Am J Pathol 1992;141:973-980.
39. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, et al. Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000;92:475-480.
40. Arapshian A, Bertran S, Kuppumbatti YS, et al. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer. Mol Cancer 2004;3:13.
41. Jeronimo C, Henrique R, Oliveira J, et al. Aberrant cellular retinol binding protein 1 (CRBP1) gene expression and promoter methylation in prostate cancer. J Clin Pathol 2004;57:872-876.
42. Esteller M, Guo M, Moreno V, et al. Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human Cancer. Cancer Res 2002;62:5902-5905.
43. Rousseau C, Pettersson F, Couture MC, et al. N-terminal of the estrogen receptor (ERalpha) mediates transcriptional cross-talk with the retinoic acid receptor in human breast cancer cells. J Steroid Biochem Mol Biol 2003;86:1-14.